NYSE:AMRX

Amneal Pharmaceuticals Stock Insider Trading

Healthcare > Drug Manufacturers - Specialty & Generic

Buy AMRX

*Your capital is at risk

$16.11

-0.100 (-0.617%)

At Close: Jun 22, 2026

Amneal Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 60.88. In total, the insiders bought 8.28M and sold 1.75M AMRX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	60.88
● Buy	8.28M shares
● Sell	1.75M shares
74% Buy Activity Negligible or No Correlation
Buy Signal Medium Confidence Mar 03, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 60.88. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 03, 2026 Buy	Class A Common Stock M-Exempt	Boyer Andrew S Executive Vice President	CEO / President	39 252 Value: $522.4K
Mar 03, 2026 Sell	Class A Common Stock F-InKind	Boyer Andrew S Executive Vice President	CEO / President	12 154 Value: $161.8K
Mar 03, 2026 Buy	Class A Common Stock M-Exempt	Boyer Andrew S Executive Vice President	CEO / President	49 694 Value: $661.4K
Mar 03, 2026 Buy	Class A Common Stock M-Exempt	Konidaris Tasos Executive Vice President & CFO	CEO / President	28 538 Value: $379.8K
Mar 03, 2026 Buy	Restricted Stock Units M-Exempt	Daly Jason B. EVP, Chief Legal Officer	Officer	22 645 Value: $301.4K
Mar 03, 2026 Buy	Class A Common Stock M-Exempt	Daly Jason B. EVP, Chief Legal Officer	Officer	22 645 Value: $301.4K
Mar 03, 2026 Sell	Class A Common Stock F-InKind	Daly Jason B. EVP, Chief Legal Officer	Officer	16 598 Value: $220.9K
Mar 03, 2026 Buy	Class A Common Stock M-Exempt	Daly Jason B. EVP, Chief Legal Officer	Officer	24 258 Value: $322.9K
Mar 03, 2026 Buy	Restricted Stock Units M-Exempt	Daly Jason B. EVP, Chief Legal Officer	Officer	24 258 Value: $322.9K
Mar 03, 2026 Buy	Performance-Based Restricted Stock Units M-Exempt	Patel Chirag K. President & Co-ceo	CEO / President	733 944 Value: $9.77M
Mar 03, 2026 Buy	Class A Common Stock M-Exempt	Patel Chirag K. President & Co-ceo	CEO / President	59 931 Value: $797.7K
Mar 03, 2026 Buy	Class A Common Stock M-Exempt	Patel Chirag K. President & Co-ceo	CEO / President	733 944 Value: $9.77M
Mar 03, 2026 Buy	Performance-Based Restricted Stock Units M-Exempt	Patel Chintu Co-ceo	CEO / President	733 944 Value: $9.77M
Mar 03, 2026 Buy	Restricted Stock Units M-Exempt	Patel Chintu Co-ceo	CEO / President	59 931 Value: $797.7K
Mar 03, 2026 Sell	Class A Common Stock F-InKind	Patel Chintu Co-ceo	CEO / President	17 112 Value: $227.8K
Mar 03, 2026 Buy	Class A Common Stock M-Exempt	Patel Chintu Co-ceo	CEO / President	59 931 Value: $797.7K
Mar 03, 2026 Sell	Class A Common Stock F-InKind	Patel Chintu Co-ceo	CEO / President	315 885 Value: $4.20M
Mar 03, 2026 Buy	Class A Common Stock M-Exempt	Patel Chintu Co-ceo	CEO / President	733 944 Value: $9.77M
Mar 03, 2026 Sell	Class A Common Stock F-InKind	Konidaris Tasos Executive Vice President & CFO	CEO / President	229 817 Value: $3.06M
Mar 03, 2026 Buy	Class A Common Stock M-Exempt	Konidaris Tasos Executive Vice President & CFO	CEO / President	57 339 Value: $763.2K
Mar 03, 2026 Sell	Class A Common Stock F-InKind	Konidaris Tasos Executive Vice President & CFO	CEO / President	14 298 Value: $190.3K
Mar 03, 2026 Sell	Class A Common Stock F-InKind	Konidaris Tasos Executive Vice President & CFO	CEO / President	24 251 Value: $322.8K
Mar 03, 2026 Buy	Class A Common Stock M-Exempt	Konidaris Tasos Executive Vice President & CFO	CEO / President	45 290 Value: $602.8K
Mar 03, 2026 Sell	Class A Common Stock F-InKind	Konidaris Tasos Executive Vice President & CFO	CEO / President	16 182 Value: $215.4K
Mar 03, 2026 Buy	Restricted Stock Units M-Exempt	Konidaris Tasos Executive Vice President & CFO	CEO / President	28 538 Value: $379.8K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT AMNEAL PHARMACEUTICALS, INC.

Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation produc...

Read Full Profile Here